Maeyama K - Search Results

1

The disposition of thioperamide, a histamine H3-receptor antagonist, in rats.

Sakurai E, Gunji E, Iizuka Y, Hikichi N, Maeyama K, Watanabe T. Sakurai E, et al. Among authors: maeyama k. J Pharm Pharmacol. 1994 Mar;46(3):209-12. doi: 10.1111/j.2042-7158.1994.tb03780.x. J Pharm Pharmacol. 1994. PMID: 8027929

2

Enantioselective pharmacokinetics of alpha-fluoromethylhistidine in rats and its comparison with histidine.

Sakurai E, Yamasaki S, Iizuka Y, Hikichi N, Maeyama K, Watanabe T. Sakurai E, et al. Among authors: maeyama k. J Pharm Pharmacol. 1992 Nov;44(11):921-5. doi: 10.1111/j.2042-7158.1992.tb03237.x. J Pharm Pharmacol. 1992. PMID: 1361538

3

Effects of the histamine H3 receptor ligands thioperamide and (R)-alpha-methylhistamine on histidine decarboxylase activity of mouse brain.

Sakai N, Sakurai A, Sakurai E, Yanai K, Maeyama K, Watanabe T. Sakai N, et al. Among authors: maeyama k. Biochem Biophys Res Commun. 1992 May 29;185(1):121-6. doi: 10.1016/s0006-291x(05)80964-7. Biochem Biophys Res Commun. 1992. PMID: 1599447

4

The disposition of a histidine decarboxylase inhibitor (S)-alpha-fluoromethylhistidine in rats.

Sakurai E, Niwa H, Yamasaki S, Maeyama K, Watanabe T. Sakurai E, et al. Among authors: maeyama k. J Pharm Pharmacol. 1990 Dec;42(12):857-60. doi: 10.1111/j.2042-7158.1990.tb07040.x. J Pharm Pharmacol. 1990. PMID: 1983148

5

Effects of thioperamide, a histamine H3 antagonist, on the step-through passive avoidance response and histidine decarboxylase activity in senescence-accelerated mice.

Meguro K, Yanai K, Sakai N, Sakurai E, Maeyama K, Sasaki H, Watanabe T. Meguro K, et al. Among authors: maeyama k. Pharmacol Biochem Behav. 1995 Mar;50(3):321-5. doi: 10.1016/0091-3057(95)00248-u. Pharmacol Biochem Behav. 1995. PMID: 7617668

6

In vivo microdialysis measurement of histamine in rat blood effects of compound 48/80 and histamine receptor antagonists.

Sakurai E, Gunji E, Iizuka Y, Hikichi N, Maeyama K, Watanabe T. Sakurai E, et al. Among authors: maeyama k. J Pharmacol Toxicol Methods. 1993 Apr;29(2):105-9. doi: 10.1016/1056-8719(93)90058-m. J Pharmacol Toxicol Methods. 1993. PMID: 7686411

7

Clobenpropit (VUF-9153), a new histamine H3 receptor antagonist, inhibits electrically induced convulsions in mice.

Yokoyama H, Onodera K, Maeyama K, Sakurai E, Iinuma K, Leurs R, Timmerman H, Watanabe T. Yokoyama H, et al. Among authors: maeyama k. Eur J Pharmacol. 1994 Jul 21;260(1):23-8. doi: 10.1016/0014-2999(94)90005-1. Eur J Pharmacol. 1994. PMID: 7957622

8

The disposition of (R)-alpha-methylhistamine, a histamine H3-receptor agonist, in rats.

Yamasaki S, Sakurai E, Hikichi N, Sakai N, Maeyama K, Watanabe T. Yamasaki S, et al. Among authors: maeyama k. J Pharm Pharmacol. 1994 May;46(5):371-4. doi: 10.1111/j.2042-7158.1994.tb03815.x. J Pharm Pharmacol. 1994. PMID: 8083809

9

Effects of the histamine H3 agonist (R)-alpha-methylhistamine and the antagonist thioperamide in vitro on monoamine oxidase activity in the rat brain.

Sakurai E, Sakurai E, Maeyama K, Watanabe T, Jossan SS, Oreland L. Sakurai E, et al. Among authors: maeyama k. Methods Find Exp Clin Pharmacol. 1995 Nov;17 Suppl C:46-50. Methods Find Exp Clin Pharmacol. 1995. PMID: 8750795

10

Effects of inhibitors of protein kinase C on the release and synthesis of histamine in rat basophilic leukemia cells (2H3).

Maeyama K, Taguchi Y, Sakurai E, Sasaki M, Yamatodani A, Watanabe T. Maeyama K, et al. Jpn J Pharmacol. 1992 Mar;58(3):291-8. doi: 10.1254/jjp.58.291. Jpn J Pharmacol. 1992. PMID: 1381000 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters